Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Sell
160,444
-2,411
-1% -$535K 2.11% 6
2025
Q4
$37.2M Sell
162,855
-8,270
-5% -$1.88M 2.18% 7
2025
Q3
$39.6M Sell
171,125
-2,568
-1% -$523K 2.33% 7
2025
Q2
$32.2M Sell
173,693
-6,149
-3% -$1.14M 2.09% 10
2025
Q1
$37.7M Sell
179,842
-3,366
-2% -$654K 2.52% 6
2024
Q4
$32.6M Sell
183,208
-2,728
-1% -$502K 2.15% 8
2024
Q3
$36.7M Sell
185,936
-2,276
-1% -$425K 2.44% 6
2024
Q2
$32.3M Sell
188,212
-3,873
-2% -$642K 2.26% 6
2024
Q1
$35M Sell
192,085
-2,448
-1% -$422K 2.49% 4
2023
Q4
$30.1M Sell
194,533
-585
-0.3% -$85.3K 2.48% 4
2023
Q3
$29.1M Buy
195,118
+681
+0.4% +$100K 2.55% 4
2023
Q2
$26.2M Buy
194,437
+7,978
+4% +$1.17M 2.17% 6
2023
Q1
$29.7M Sell
186,459
-2,277
-1% -$348K 2.61% 3
2022
Q4
$30.5M Sell
188,736
-4,900
-3% -$751K 2.77% 4
2022
Q3
$26M Sell
193,636
-2,161
-1% -$310K 2.46% 4
2022
Q2
$30M Sell
195,797
-5,684
-3% -$869K 2.63% 4
2022
Q1
$32.7M Sell
201,481
-5,459
-3% -$793K 2.38% 5
2021
Q4
$28M Sell
206,940
-2,179
-1% -$257K 1.94% 6
2021
Q3
$22.6M Buy
209,119
+357
+0.2% +$40.8K 1.72% 10
2021
Q2
$23.5M Buy
208,762
+5,527
+3% +$622K 1.79% 8
2021
Q1
$22M Buy
203,235
+2,924
+1% +$313K 1.8% 10
2020
Q4
$21.5M Buy
200,311
+5,560
+3% +$534K 1.87% 8
2020
Q3
$17.1M Buy
194,751
+8,994
+5% +$847K 1.7% 10
2020
Q2
$18.2M Buy
185,757
+1,444
+0.8% +$127K 2% 9
2020
Q1
$14M Buy
184,313
+1,332
+0.7% +$113K 1.85% 10
2019
Q4
$16.2M Buy
182,981
+16,189
+10% +$1.34M 1.63% 12
2019
Q3
$12.6M Buy
166,792
+385
+0.2% +$26.4K 1.38% 18
2019
Q2
$12.1M Sell
166,407
-9,133
-5% -$718K 1.31% 21
2019
Q1
$14.1M Sell
175,540
-1,710
-1% -$140K 1.55% 15
2018
Q4
$16.3M Sell
177,250
-10,012
-5% -$880K 2% 5
2018
Q3
$17.7M Buy
187,262
+2,770
+2% +$263K 1.75% 7
2018
Q2
$17.1M Buy
184,492
+1,484
+0.8% +$145K 1.76% 8
2018
Q1
$17.3M Sell
183,008
-994
-0.5% -$109K 1.77% 9
2017
Q4
$17.8M Sell
184,002
-4,178
-2% -$394K 1.78% 8
2017
Q3
$16.7M Sell
188,180
-5,551
-3% -$423K 1.76% 9
2017
Q2
$14M Buy
193,731
+3,389
+2% +$228K 1.55% 12
2017
Q1
$12.4M Sell
190,342
-10,986
-5% -$691K 1.43% 13
2016
Q4
$12.6M Sell
201,328
-20,485
-9% -$1.25M 1.55% 12
2016
Q3
$14M Sell
221,813
-9,124
-4% -$591K 1.8% 9
2016
Q2
$14.3M Sell
230,937
-6,825
-3% -$416K 1.98% 9
2016
Q1
$13.6M Buy
237,762
+2,905
+1% +$162K 1.94% 9
2015
Q4
$13.9M Buy
234,857
+3,922
+2% +$226K 1.92% 8
2015
Q3
$12.6M Buy
230,935
+20,232
+10% +$1.32M 1.92% 9
2015
Q2
$14.2M Buy
210,703
+7,766
+4% +$507K 2.06% 8
2015
Q1
$11.9M Buy
202,937
+39,055
+24% +$2.36M 1.71% 9
2014
Q4
$10.7M Buy
163,882
+11,275
+7% +$711K 1.62% 10
2014
Q3
$8.81M Buy
152,607
+121,130
+385% +$6.72M 1.4% 21
2014
Q2
$1.78M Buy
31,477
+8,843
+39% +$464K 0.29% 83
2014
Q1
$1.16M Buy
22,634
+916
+4% +$46.3K 0.16% 113
2013
Q4
$1.15M Buy
21,718
+2,265
+12% +$111K 0.16% 114
2013
Q3
$870K Sell
19,453
-180
-0.9% -$7.98K 0.14% 129
2013
Q2
$812K Buy
+19,633
New +$859K 0.13% 130

Other funds holding ABBV

Patten & Patten's ABBV Position: Q1 2026 in Review

Patten & Patten reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $535K and leaving 160,444 shares worth $34.9M. The position accounts for 2.11% of the portfolio, ranked #6.

Patten & Patten first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $39.6M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Patten & Patten held 160,444 shares of AbbVie worth $34.9M as of Q1 2026.
  • Patten & Patten sold 2,411 AbbVie shares in Q1 2026, an estimated $535K.
  • AbbVie made up 2.11% of Patten & Patten's portfolio in Q1 2026, its #6 holding.
  • Patten & Patten first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Patten & Patten's AbbVie position peaked at $39.6M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Patten & Patten's 13F filing for Q1 2026, filed 1 May 2026.